Technavio has been monitoring the global orthotic foot insoles market size and it is poised to grow by USD 1.12 billion during 2020-2024, progressing at a CAGR of over 6% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201012005427/en/
Technavio has announced its latest market research report titled Global Orthotic Foot Insoles Market 2020-2024 (Graphic: Business Wire)
Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download Latest Free Sample Report on COVID-19 Analysis
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Bauerfeind AG, Bayer AG, Footlogics Australia Pty Ltd., Guangzhou Shunyang SM Co. Ltd., Hanger Inc., Implus LLC, Ottobock SE & Co. KGaA,
U.S. infections have been rising for several weeks, a worrying sign with colder weather approaching. The response to the crisis rests largely with governors, which has meant a patchwork of approaches. Only a handful of countries rank higher in COVID-19 deaths per capita.
A University of Central Florida researcher is part of a new study showing that artificial intelligence can be nearly as accurate as a physician in diagnosing COVID-19 in the lungs.
The study, recently published in Nature Communications, shows the new technique can also overcome some of the challenges of current testing.
Researchers demonstrated that an AI algorithm could be trained to classify COVID-19 pneumonia in computed tomography (CT) scans with up to 90 percent accuracy, as well as correctly identify positive cases 84 percent of the time and negative cases 93 percent of the time.
CT scans offer a deeper insight into COVID-19 diagnosis and progression as compared to the often-used reverse transcription-polymerase chain reaction, or RT-PCR, tests. These tests have high false negative rates, delays in processing and other challenges.
Another benefit to CT scans is that they can detect COVID-19 in people without symptoms, in those who have
MONTREAL — Quebec is getting ready to introduce the federal government’s COVID-19 contact tracing application in the coming days as infections in the province remain on the rise.
Premier Francois Legault told reporters Tuesday in Quebec City the app will be deployed after officials concluded it would take too long to introduce the made-in-Quebec application they had hoped for.
Quebec reported 799 new COVID-19 cases and seven more deaths linked to the novel coronavirus on Tuesday, along with a spike in hospitalizations.
The province has had problems with contact tracing, with health officials in Montreal reporting difficulties tracking down people who were potentially exposed.
Health Minister Christian Dube said Quebec officials looked more closely at the smartphone application during a meeting with Ontario counterparts 10 days ago. While Ontario isn’t fully satisfied, Dube said he hopes Quebecers will use it in large
Technavio has been monitoring the anesthesia laryngeal masks market and it is poised to grow by USD 55.76 million during 2020-2024. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200928005773/en/
Technavio has announced its latest market research report titled Global Anesthesia Laryngeal Masks Market 2020-2024 (Graphic: Business Wire)
Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization
The market is fragmented, and the degree of fragmentation
Google parent Alphabet has settled a shareholder lawsuit that accused the company of mishandling sexual harassment claims.
The settlement eliminates forced arbitration for employees, and limit the use of non-disclosure agreements.
It’s also agreed to spend $310 million on corporate diversity programs over the next decade.
Visit Business Insider’s homepage for more stories.
Alphabet has settled a shareholder lawsuit that accused the company’s board of mishandling sexual harassment claims.
As per details shared by one of the plaintiffs’ attorneys, the settlement eliminates the forcing of employees involved in discrimination or harassment disputes to settle with private arbitration, and limits Google’s use of non-disclosure agreements.
It was also agreed that employees who depart the company while under investigation for claims of sexual misconduct will not receive any severance or compensation.
Google also agreed to spend $310 million on corporate diversity programs over 10 years as part of the settlement. Those efforts
People infected by the novel coronavirus can have symptoms that range from mild to deadly. Now, two new analyses suggest that some life-threatening cases can be traced to weak spots in patients’ immune systems.
At least 3.5 percent of study patients with severe COVID-19, the disease caused by the novel coronavirus, have mutations in genes involved in antiviral defense. And at least 10 percent of patients with severe disease create “auto-antibodies” that attack the immune system, instead of fighting the virus. The results, reported in two papers in the journal Science on September 24, 2020, identify some root causes of life-threatening COVID-19, says study leader Jean-Laurent Casanova, a Howard Hughes Medical Institute Investigator at The Rockefeller University.
Seeing these harmful antibodies in so many patients — 101 out of 987 — was “a stunning observation,” he says. “These two papers provide the first explanation for why COVID-19 can be so
Since the first 20 Oversight Board members were appointed back in May, we have been helping to get them up and running as quickly as possible. That has included finalizing a new software tool that allows members to securely access and review case information from anywhere in the world; and training them on our Community Standards and policy development processes. We look forward to the board beginning to hear cases in mid to late October.
Shortly after launching the board, Facebook announced that it wouldn’t be ready until “late fall,” leading to fears that it would arrive too late for the US elections. It appears now that it will come sooner, though with not a lot of time to spare before votes are cast on November 3rd. Plus, decisions could take as long as three months after an appeal is first heard.
The IDF’s Home Front Command’s Alon task force and it’s Epidemiological Investigation Center can effectively deal with 2,000 cases a day with some 2,500 investigators but should the need for additional investigators increase, its capabilities will decrease.“We are building a very good system which can carry out a good number of quality investigations but every good machine has a limit,” Col. Relli Margalit, Commander of the Epidemiological Investigation Center told The Jerusalem Post. Earlier this week the IDF announced the establishment of the Home Front Command’s “Ella” unit which would carry out epidemiological investigations with new technology that would help the Health Ministry by streamlining and improving its ability to cut the chain of coronavirus infection.“The Health Ministry is great, but its small and can’t deal with everything. Of course, the military can’t deal with everything either but the Home Front Command is here to help solve problems that